A Phase 1 Study of the Safety and Tolerability of CTX-10726
Compass Therapeutics
Compass Therapeutics
GlaxoSmithKline
Qilu Pharmaceutical Co., Ltd.
Convalife (Shanghai) Co., Ltd.
Rutgers, The State University of New Jersey
Kaiser Permanente
Ellele Health
Mayo Clinic
University Hospital, Strasbourg, France
Cogent Biosciences, Inc.
Peking University People's Hospital
European Institute of Oncology
UNC Lineberger Comprehensive Cancer Center
Women's Hospital School Of Medicine Zhejiang University
Taipei Veterans General Hospital, Taiwan
European Institute of Oncology
Natera, Inc.
Medical College of Wisconsin
UNC Lineberger Comprehensive Cancer Center
Second Life Therapeutics
Rocky Vista University, LLC
University of Rochester
Sun Yat-sen University
Centre Leon Berard
University College, London
GlaxoSmithKline
Peking University People's Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
University Health Network, Toronto
Peking University People's Hospital
University of South Florida
Istanbul University
Universidade Federal de Pernambuco
Akdeniz University
Peking Union Medical College Hospital
Peking Union Medical College Hospital
BioMimetix JV, LLC
Danatlas Pharmaceuticals Co., Ltd
Fudan University
Peking University People's Hospital
Sohag University
Peking University People's Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Zhongnan Hospital
Sun Yat-sen University
Fujian Cancer Hospital
Chang Gung Memorial Hospital
Peking Union Medical College Hospital
Fudan University
Peking University Third Hospital